Atorvastatin calcium trihydrate

This classification denotes a hmg-coa reductase inhibitor with the molecular formula 2C33H34FN2O5.Ca.3H2O, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier 48A5M73Z4Q, chemically known as 1h-pyrrole-1-heptanoic acid, beta,delta-dihydroxy-2-(4-fluorophenyl)-5-(1-methylethyl)-3-phenyl-4-((phenylamino)carbonyl)-, calcium salt (2:1), (r-(r*,r*))- but more generally known as atorvastatin calcium, which bears US NIH Compound Identifier 60822. European Medicines Agency schedules Atorvastatin calcium in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB12958MIG. Most nations, for tariff and trade purposes, schedule atorvastatin calcium trihydrate under HS 29339990 and SITC 51577. As of Q4 2014, ATORVASTATIN CALCIUM TRIHYDRATE remains US FDA's Preferred Term for this commodity. SMILES: CC(C)C1C(C(C(N1CC[C@H](C[C@H](CC(=O)[O-])O)O)C2CCC(CC2)F)C3CCCCC3)C(=O)NC4CCCCC4.CC(C)C1C(C(C(N1CC[C@H](C[C@H](CC(=O)[O-])O)O)C2CCC(CC2)F)C3CCCCC3)C(=O)NC4CCCCC4.O.O.O.[CA+2].